| FSMAX | VNVNX | FSMAX / VNVNX | |
| Total Expense Ratio | 0.04 | 0.85 | 4% |
| Annual Report Gross Expense Ratio | 0.04 | 0.91 | 4% |
| Fund Existence | 14 years | 13 years | - |
| Gain YTD | 13.303 | -21.012 | -63% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 41B | 160M | 25,625% |
| Annual Yield % from dividends | 0.43 | 0.07 | 635% |
| Returns for 1 year | 10.55 | -22.74 | -46% |
| Returns for 3 years | 67.63 | -2.51 | -2,693% |
| Returns for 5 years | 26.24 | -9.98 | -263% |
| Returns for 10 years | 118.30 | -3.69 | -3,210% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RYWTX | 99.06 | 1.74 | +1.79% |
| Rydex Emerging Markets 2X Strategy A | |||
| TIDDX | 75.26 | 0.11 | +0.15% |
| T. Rowe Price International Discovery I | |||
| INTIX | 14.12 | 0.01 | +0.07% |
| Voya International Index Port S | |||
| HNISX | 15.56 | 0.01 | +0.06% |
| Harbor International Small Cap Retire | |||
| ETIHX | 52.77 | -0.40 | -0.75% |
| Eventide Healthcare & Life Sciences I | |||